Did antiphospholipid antibodies limit intervention efficacy for postoperative total knee arthroplasty-related thrombotic event prevention? Comment on the article by Smith et al
- PMID: 32004422
- DOI: 10.1002/acr.24162
Did antiphospholipid antibodies limit intervention efficacy for postoperative total knee arthroplasty-related thrombotic event prevention? Comment on the article by Smith et al
Comment in
-
Reply.Arthritis Care Res (Hoboken). 2020 May;72(5):738-739. doi: 10.1002/acr.24161. Arthritis Care Res (Hoboken). 2020. PMID: 32058676 No abstract available.
Comment on
-
Cost-Effectiveness of Alternative Anticoagulation Strategies for Postoperative Management of Total Knee Arthroplasty Patients.Arthritis Care Res (Hoboken). 2019 Dec;71(12):1621-1629. doi: 10.1002/acr.23803. Epub 2019 Nov 5. Arthritis Care Res (Hoboken). 2019. PMID: 30369093 Free PMC article.
References
-
- Smith SR, Katz JN, Losina E. Cost-effectiveness of alternative anticoagulation strategies for postoperative management of total knee arthroplasty patients. Arthritis Care Res (Hoboken) 2019;71:1621-9.
-
- Cohen D, Berger SP, Steup-Beekman GM, Bloemenkamp KW, Bajema IM. Diagnosis and management of the antiphospholipid syndrome [editorial]. BMJ 2010;340:2541.
-
- Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Eng J Med 2018;378:2010-21.
-
- Rothschild BM. Comparative anti-platelet activity of COX-1 NSAIDS versus aspirin, encompassing regimen simplification and gastroprotection: a call for a controlled study. Reumatismo 2004;56:89-93.
-
- Perneby C, Wallén NH, Rooney C, Fitzgerald D, Hjemdahl P. Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost 2006;95:652-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
